Bob Tambo recently surprised his occupational therapist with a portrait as a token of appreciation for his recovery.

This expansion will likely bring forth new technologies and competitors, ultimately enhancing patient outcomes. As the demand for infusion therapy space grows also within the alternative care ...

Judy Perkins’ stage 4 cancer was eradicated after she joined a clinical trial for T-cell therapy. She shares her ... I called my cousin, a patient advocate for many years, for advice.

But most drug labels and patient handouts don't list every possible drug interaction. Talk to your pharmacist to get the full picture. They can also answer any questions about medical terms or ...

As a sensitivity analysis, these data were also assessed excluding those patients who switched from initial therapy. As additional outcome measures, the study assessed relationships between 1-year ...

III) any B cell-depleting therapies, other than ianalumab administered within 36 weeks prior to randomization or as long as B cell count is less than the lower limit of normal or baseline value prior ...

An illustration of a magnifying glass. An illustration of a magnifying glass.